Oral artemether for prevention of Schistosoma mansoni infection: Randomised controlled trial

Lancet

Volumn 355, Issue 9212, 2000, Pages 1320-1325

  Utzinger, Jürg ^a,b   N'Goran, Eliézer K ^b,c   N'Dri, Amani ^d   Lengeler, Christian ^a   Shuhua, Xiao ^a,e   Tanner, Marcel ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Centre Suisse de Recherches Scientifiques   (Switzerland)

^c Université de Cocody   (Switzerland)

^d Grandes Endémies de Man   (Switzerland)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; PLACEBO; PRAZIQUANTEL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COTE D'IVOIRE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FECES ANALYSIS; HUMAN; INCIDENCE; INTERVIEW; MALARIA FALCIPARUM; NORMAL HUMAN; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHOOL; SCHOOL CHILD;

EID: 0034656258     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02114-0     Document Type: Article

References (31)

1. Doumenge J.P., Mott K.E., Cheung C.et al. Atlas of the global distribution of schistosomiasis. 1987;WHO, Geneva.
2. The control of schistosomiasis: second report of the WHO expert committee. WHO Technical Report Series, No 830. 1993;WHO, Geneva.
3. Bergquist N.R., Colley D.G. Schistosomiasis vaccines. research to development Parasitol Today. 14:1998;99-104.
4. Capron A. Schistosomiasis. forty years' war on the worm Parasitol Today. 14:1998;379-384.
5. King C.H., Wiper D.W., De Stigter K.V.et al. Dose-finding study for praziquantel therapy of Schistosoma haematobium in Coast province, Kenya. Am J Trop Med Hyg. 40:1989;507-513.
6. Kumar V., Gryseels B. Use of praziquantel against schistosomiasis. a review of current status Int J Antimicrob Agents. 4:1994;313-320.
7. Gryseels B., Stelma F.F., Talla I.et al. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop Geogr Med. 46:1994;209-219.
8. Stelma F.F., Talla I., Sow S.et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg. 53:1995;167-170.
9. Guissé F., Polman K., Stelma F.F.et al. Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal. Am J Trop Med Hyg. 56:1997;511-514.
10. Fallon P.G., Doenhoff M.J. Drug-resistant schistosomiasis. resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific Am J Trop Med Hyg. 51:1994;83-88.
11. Cioli D. Chemotherapy of schistosomiasis. an update Parasitol Today. 14:1998;418-422.
12. Kusel J., Hagan P. Praziquantel - its use, cost and possible development of resistance. Parasitol Today. 15:1999;352-354.
13. Wilkins H.A. Reinfection after treatment of schistosomiasis infections. Parasitol Today. 5:1989;83-88.
14. Xiao S.H., Booth M., Tanner M. The prophylactic effect of artemether against Schistosoma japonicum infections. Parasitol Today. 16:2000;122-126.
15. Bout D.T., Deslée D., Capron A. Protection against schistosomiasis produced by cyclosporin A. Am J Trop Med Hyg. 33:1984;185-186.
16. Klayman D.L. Qinghaosu (artemisinin). an antimalarial drug from China Science. 228:1985;1049-1055.
17. McIntosh H.M., Olliaro P. Artemisinin derivatives for treating severe malaria (Cochrane Review). In: Cochrane Library, issue 4. 1999;Update Software, Oxford.
18. Xiao S.H., You J.Q., Yang Y.Q., Wang C.Z. Experimental studies on early treatment of schistosomal infection with artemether. Southeast Asian J Trop Med Public Health. 26:1995;306-318.
19. Xiao S.H., You J.Q., Mei J.Y., Jiao P.Y., Guo H.F., Feng Z. Preventive effect of artemether in rabbits infected with Schistosoma japonicum cercariae. Acta Pharmacol Sin. 19:1998;63-66.
20. Xiao S.H., Catto B.A. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother. 33:1989;1557-1562.
21. Xiao S.H., Chollet J., Weiss N.A., Bergquist R.N., Tanner M. Preventive effect of artemether in experimental animals infected with Schistosoma mansoni. Parasitol Int. 49:2000;19-24.
22. Sabah A.A., Fletcher C., Webbe G., Doenhoff M.J. Schistosoma mansoni. chemotherapy of infections of different ages Exp Parasitol. 61:1986;294-303.
23. N'Goran K.E., Yapi Y., Bellec C., Sellin B. Données préliminaires sur les variations journalières des densités cercariennes de Schistosoma mansoni dans deux foyers forestiers de schistosomose intestinale de la région de Man (Côte d'Ivoire). Bull Méd Pharm. 3:1989;117-127.
24. Utzinger J., N'Goran E.K., Ossey Y.A.et al. Rapid screening for Schistosoma mansoni in western Côte d'Ivoire. Bull World Health Organ. 78:2000;389-398.
25. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 14:1972;397-400.
26. Marti H.P., Escher E. SAF - eine alternative Fixierlösung für parasitologische Stuhluntersuchungen. Schweiz Med Wochenschr. 120:1990;1473-1476.
27. Conway M.R. A random effects model for binary data. Biometrics. 46:1990;317-328.
28. Utzinger J., N'Goran E.K., Esse Aya C.M.et al. Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire. Trop Med Int Health. 3:1998;711-720.
29. De Vlas S.J., Gryseels B. Underestimation of Schistosoma mansoni prevalences. Parasitol Today. 8:1992;274-277.
30. Li S., Wu L., Liu Z.et al. Studies on prophylactic effect on schistosomiasis japonica. Chin Med J. 109:1996;848-853.
31. White N.J., Nosten F., Looareesuwan S.et al. Averting a malaria disaster. Lancet. 353:1999;1965-1967.